Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Cutting-Edge Dermatology: From Lentigo Maligna to IL-13 Fibrosis
This week's dermatology update covers consensus guidelines for lentigo maligna and tinea capitis, breakthrough research on Darier disease and tissue-resident memory T cells, safety data on JAK-STAT inhibitors, and emerging therapies targeting IL-13 fibrosis pathways.
Bibliography
1. International Dermoscopy Society consensus recommendations for the management of lentigo maligna.
Authors: Forsea AM, Pampena R, Akay BN, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 41854120
DOI: 10.1111/jdv.70406
2. Consensus-based Guideline on tinea capitis.
Authors: Mayser P, Abeck D, Bosshard PP, et al.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026 Oct
PMID: 42444404
DOI: 10.1111/ddg.70395x
3. Darier disease-A review highlighting new insights from the Darier Disease International Task Force.
Authors: Labbouz S, Hovnanian A, Xiong G, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42223188
DOI: 10.1111/jdv.70483
4. The Role of Tissue Resident Memory Cells in Immunodermatological Disorders.
Authors: De A, Chakraborty D, Desai S, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42473984
DOI: 10.1111/ijd.70594
5. Large-scale meta-analysis of infection risk with JAK-STAT inhibitors in 29,000 patients.
Authors: Krebs M, Gulyás L, Fazekas KK, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42187316
DOI: 10.1111/jdv.70508
6. Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials.
Authors: Stein Gold L, Armstrong AW, Soung J, et al.
Journal: The British journal of dermatology, 2026 Sep 18
PMID: 42397072
DOI: 10.1093/bjd/ljag264
7. Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
Authors: Peters RHW, Smits JPH, van den Bogaard EH, et al.
Journal: The Journal of investigative dermatology, 2026 Oct
PMID: 42246919
DOI: 10.1016/j.jid.2026.04.032
8. Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.
Authors: Chernyshov PV, Jemec G, Finlay A, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42144705
DOI: 10.1111/ijd.70443
9. Primary Hyperhidrosis: A Review of Epidemiology, Pathophysiology and Management.
Authors: Shayesteh A
Journal: Acta dermato-venereologica, 2026 Sep 16
PMID: 42747166
DOI: 10.2340/actadv.v106.adv-2026-0770
10. IL-13 and skin fibrosis in inflammatory skin diseases.
Authors: Ikegawa N, Nguyen TM, Saito-Sasaki N, et al.
Journal: Frontiers in immunology, 2026
PMID: 42851899
DOI: 10.3389/fimmu.2026.1974049
Authors: Forsea AM, Pampena R, Akay BN, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 41854120
DOI: 10.1111/jdv.70406
2. Consensus-based Guideline on tinea capitis.
Authors: Mayser P, Abeck D, Bosshard PP, et al.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2026 Oct
PMID: 42444404
DOI: 10.1111/ddg.70395x
3. Darier disease-A review highlighting new insights from the Darier Disease International Task Force.
Authors: Labbouz S, Hovnanian A, Xiong G, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42223188
DOI: 10.1111/jdv.70483
4. The Role of Tissue Resident Memory Cells in Immunodermatological Disorders.
Authors: De A, Chakraborty D, Desai S, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42473984
DOI: 10.1111/ijd.70594
5. Large-scale meta-analysis of infection risk with JAK-STAT inhibitors in 29,000 patients.
Authors: Krebs M, Gulyás L, Fazekas KK, et al.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV, 2026 Oct
PMID: 42187316
DOI: 10.1111/jdv.70508
6. Durability of response to icotrokinra in adults with moderate-to-severe plaque psoriasis: 1-year results from the phase III, placebo- and active comparator-controlled ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 trials.
Authors: Stein Gold L, Armstrong AW, Soung J, et al.
Journal: The British journal of dermatology, 2026 Sep 18
PMID: 42397072
DOI: 10.1093/bjd/ljag264
7. Advantages and limitations of in vitro models for atopic dermatitis: A consensus expert opinion.
Authors: Peters RHW, Smits JPH, van den Bogaard EH, et al.
Journal: The Journal of investigative dermatology, 2026 Oct
PMID: 42246919
DOI: 10.1016/j.jid.2026.04.032
8. Position Statement of the EADV Task Forces With External Experts on Quality of Life Measurement in Hidradenitis Suppurativa: An Update.
Authors: Chernyshov PV, Jemec G, Finlay A, et al.
Journal: International journal of dermatology, 2026 Oct
PMID: 42144705
DOI: 10.1111/ijd.70443
9. Primary Hyperhidrosis: A Review of Epidemiology, Pathophysiology and Management.
Authors: Shayesteh A
Journal: Acta dermato-venereologica, 2026 Sep 16
PMID: 42747166
DOI: 10.2340/actadv.v106.adv-2026-0770
10. IL-13 and skin fibrosis in inflammatory skin diseases.
Authors: Ikegawa N, Nguyen TM, Saito-Sasaki N, et al.
Journal: Frontiers in immunology, 2026
PMID: 42851899
DOI: 10.3389/fimmu.2026.1974049
